2Q22 Comparable Revenues up 89% YoY – Baseline Business Adjusted EBITDA up 48% in the first two quarters, reaching $61.8M LTM HB4 Wheat...
Bioceres Crop Solutions Corp. (“Bioceres” or the “Company”) (NASDAQ: BIOX), a fully-integrated global provider of crop productivity solutions...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Bioceres Crop Solutions Corp. (“Bioceres”) (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the...
Company Achieves Industry Milestone as Approval Grants Headway Towards First-Ever Commercialization of Biotech Wheat Bioceres Crop Solutions...
1Q22 comparable revenues up 54% YoY, and LTM Adjusted EBITDA reached $50.2m HB4 inventory ramp-up advancing as projected – no additional...
0001769484--06-302021FYP30D4110408700.0033P20D0.003367000008000002467990false0001769484biox:BonusInPerfo...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form ...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.